{"id":34040,"date":"2016-05-24T13:43:37","date_gmt":"2016-05-24T11:43:37","guid":{"rendered":"https:\/\/swedenbio.se\/kalendarium\/the-future-of-venture-from-idea-to-patient\/"},"modified":"2023-10-11T09:31:35","modified_gmt":"2023-10-11T07:31:35","slug":"the-future-of-venture-from-idea-to-patient","status":"publish","type":"sb_events","link":"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/","title":{"rendered":"The Future of Venture &#8211; from idea to patient"},"content":{"rendered":"<table id=\"area_4\" class=\"table-multicol\" width=\"100%\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody class=\"sortable drop_zone\">\n<tr>\n<td align=\"left\">\n<div class=\"text\">\n<p><strong>From the program on 21 June:<\/strong><\/p>\n<p>09:00 \u00a6 PROGRAM FROM THE MAIN STAGE<\/p>\n<p>Ulf Stenerhag, CEO, Not for sale Ale AB<br \/>\nMats Gustafsson, Founder and CEO, Wednesday Relations AB<strong><br \/>\n<\/strong><\/p>\n<\/div>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"spacer\" align=\"center\" valign=\"middle\"><\/td>\n<\/tr>\n<tr>\n<td align=\"left\">\n<div class=\"text\">\n<p><strong><em>10:00 \u00a6 NETWORKING BREAK<\/em><\/strong><\/p>\n<p>10.30 \u00a6 Medicines<\/p>\n<p>The authorisation process for medicines<br \/>\nSpeaker: Marie G\u00e5rdmark, Director of Licensing, Medical Products Agency.<br \/>\n<strong><br \/>\nCommercialization and life in an incubator<\/strong><br \/>\nSpeaker: Magnus Lundin, CEO SISP<\/p>\n<p><em>12:00 \u00a6 NETWORKING LUNCH<\/em><\/p>\n<p>13:30 \u00a6 Medtech<\/p>\n<p>Learn how to sell medtech<br \/>\nConny Forsell from the training company Medwind<br \/>\n<strong><br \/>\nProcurement &#8211; how it works<\/strong><br \/>\nInterview and Q&amp;A with Louise Strand, Purchasing Director in Region Sk\u00e5ne and Chair of the County Council Network for Procurers<br \/>\n<strong><br \/>\nTakeover by global giant &#8211; dream or nightmare?<\/strong><br \/>\nShahram Khorsand, CEO, CareFusions<\/p>\n<p>15:15 \u00a6 Final discussion<\/p>\n<p>Where are we going? What will it look like in 10 years? Where do we want to go?<\/p>\n<p><em>15:30 \u00a6 NETWORKING BREAK<\/em><strong><br \/>\n<\/strong><\/p>\n<\/div>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"spacer\" align=\"center\" valign=\"middle\"><\/td>\n<\/tr>\n<tr>\n<td align=\"left\">\n<div class=\"text\">\n<p><strong>16:00 \u00a6 PROGRAM FROM THE MAIN STAGE<br \/>\n<\/strong><br \/>\nLesley Pennington, CEO, Bemz<br \/>\nAmin Omrani, CEO, Serendipity Ixoria<\/p>\n<p><em>17:00 AFTER WORK<\/em><\/p>\n<\/div>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>From the program on 21 June: 09:00 \u00a6 PROGRAM FROM THE MAIN STAGE Ulf Stenerhag, CEO, Not for sale Ale AB Mats Gustafsson, Founder and CEO, Wednesday Relations AB 10:00 \u00a6 NETWORKING BREAK 10.30 \u00a6 Medicines The authorisation process for medicines Speaker: Marie G\u00e5rdmark, Director of Licensing, Medical Products Agency. Commercialization and life in an [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"sb_event-category":[],"class_list":["post-34040","sb_events","type-sb_events","status-publish","hentry"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"From the program on 21 June: 09:00 \u00a6 PROGRAM FROM THE MAIN STAGE Ulf Stenerhag, CEO, Not for sale Ale AB Mats Gustafsson, Founder and CEO, Wednesday Relations AB 10:00 \u00a6 NETWORKING BREAK 10.30 \u00a6 Medicines The authorisation process for medicines Speaker: Marie G\u00e5rdmark, Director of Licensing, Medical Products Agency. Commercialization and life in an\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"SwedenBio\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"SwedenBIO - Branschorganisationen f\u00f6r svenska life science f\u00f6retag\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"The Future of Venture \u2013 from idea to patient - SwedenBIO\" \/>\n\t\t<meta property=\"og:description\" content=\"From the program on 21 June: 09:00 \u00a6 PROGRAM FROM THE MAIN STAGE Ulf Stenerhag, CEO, Not for sale Ale AB Mats Gustafsson, Founder and CEO, Wednesday Relations AB 10:00 \u00a6 NETWORKING BREAK 10.30 \u00a6 Medicines The authorisation process for medicines Speaker: Marie G\u00e5rdmark, Director of Licensing, Medical Products Agency. Commercialization and life in an\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2016-05-24T11:43:37+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2023-10-11T07:31:35+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"The Future of Venture \u2013 from idea to patient - SwedenBIO\" \/>\n\t\t<meta name=\"twitter:description\" content=\"From the program on 21 June: 09:00 \u00a6 PROGRAM FROM THE MAIN STAGE Ulf Stenerhag, CEO, Not for sale Ale AB Mats Gustafsson, Founder and CEO, Wednesday Relations AB 10:00 \u00a6 NETWORKING BREAK 10.30 \u00a6 Medicines The authorisation process for medicines Speaker: Marie G\u00e5rdmark, Director of Licensing, Medical Products Agency. Commercialization and life in an\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/kalendarium\\\/the-future-of-venture-from-idea-to-patient\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/kalendarium\\\/the-future-of-venture-from-idea-to-patient\\\/#listItem\",\"name\":\"The Future of Venture &#8211; from idea to patient\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/kalendarium\\\/the-future-of-venture-from-idea-to-patient\\\/#listItem\",\"position\":2,\"name\":\"The Future of Venture &#8211; from idea to patient\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#listItem\",\"name\":\"Home\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#organization\",\"name\":\"SwedenBIO\",\"description\":\"Branschorganisationen f\\u00f6r svenska life science f\\u00f6retag\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/author\\\/sw3denbio33\\\/#author\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/author\\\/sw3denbio33\\\/\",\"name\":\"SwedenBio\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/kalendarium\\\/the-future-of-venture-from-idea-to-patient\\\/#authorImage\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/wp-content\\\/plugins\\\/ultimate-member\\\/assets\\\/img\\\/default_avatar.jpg\",\"width\":96,\"height\":96,\"caption\":\"SwedenBio\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/kalendarium\\\/the-future-of-venture-from-idea-to-patient\\\/#webpage\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/kalendarium\\\/the-future-of-venture-from-idea-to-patient\\\/\",\"name\":\"The Future of Venture \\u2013 from idea to patient - SwedenBIO\",\"description\":\"From the program on 21 June: 09:00 \\u00a6 PROGRAM FROM THE MAIN STAGE Ulf Stenerhag, CEO, Not for sale Ale AB Mats Gustafsson, Founder and CEO, Wednesday Relations AB 10:00 \\u00a6 NETWORKING BREAK 10.30 \\u00a6 Medicines The authorisation process for medicines Speaker: Marie G\\u00e5rdmark, Director of Licensing, Medical Products Agency. Commercialization and life in an\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/kalendarium\\\/the-future-of-venture-from-idea-to-patient\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/author\\\/sw3denbio33\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/author\\\/sw3denbio33\\\/#author\"},\"datePublished\":\"2016-05-24T13:43:37+02:00\",\"dateModified\":\"2023-10-11T09:31:35+02:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/\",\"name\":\"SwedenBIO\",\"description\":\"Branschorganisationen f\\u00f6r svenska life science f\\u00f6retag\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"The Future of Venture \u2013 from idea to patient - SwedenBIO","description":"From the program on 21 June: 09:00 \u00a6 PROGRAM FROM THE MAIN STAGE Ulf Stenerhag, CEO, Not for sale Ale AB Mats Gustafsson, Founder and CEO, Wednesday Relations AB 10:00 \u00a6 NETWORKING BREAK 10.30 \u00a6 Medicines The authorisation process for medicines Speaker: Marie G\u00e5rdmark, Director of Licensing, Medical Products Agency. Commercialization and life in an","canonical_url":"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/swedenbio.se\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/swedenbio.se\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/#listItem","name":"The Future of Venture &#8211; from idea to patient"}},{"@type":"ListItem","@id":"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/#listItem","position":2,"name":"The Future of Venture &#8211; from idea to patient","previousItem":{"@type":"ListItem","@id":"https:\/\/swedenbio.se\/en\/#listItem","name":"Home"}}]},{"@type":"Organization","@id":"https:\/\/swedenbio.se\/en\/#organization","name":"SwedenBIO","description":"Branschorganisationen f\u00f6r svenska life science f\u00f6retag","url":"https:\/\/swedenbio.se\/en\/"},{"@type":"Person","@id":"https:\/\/swedenbio.se\/en\/author\/sw3denbio33\/#author","url":"https:\/\/swedenbio.se\/en\/author\/sw3denbio33\/","name":"SwedenBio","image":{"@type":"ImageObject","@id":"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/#authorImage","url":"https:\/\/swedenbio.se\/wp-content\/plugins\/ultimate-member\/assets\/img\/default_avatar.jpg","width":96,"height":96,"caption":"SwedenBio"}},{"@type":"WebPage","@id":"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/#webpage","url":"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/","name":"The Future of Venture \u2013 from idea to patient - SwedenBIO","description":"From the program on 21 June: 09:00 \u00a6 PROGRAM FROM THE MAIN STAGE Ulf Stenerhag, CEO, Not for sale Ale AB Mats Gustafsson, Founder and CEO, Wednesday Relations AB 10:00 \u00a6 NETWORKING BREAK 10.30 \u00a6 Medicines The authorisation process for medicines Speaker: Marie G\u00e5rdmark, Director of Licensing, Medical Products Agency. Commercialization and life in an","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/swedenbio.se\/en\/#website"},"breadcrumb":{"@id":"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/#breadcrumblist"},"author":{"@id":"https:\/\/swedenbio.se\/en\/author\/sw3denbio33\/#author"},"creator":{"@id":"https:\/\/swedenbio.se\/en\/author\/sw3denbio33\/#author"},"datePublished":"2016-05-24T13:43:37+02:00","dateModified":"2023-10-11T09:31:35+02:00"},{"@type":"WebSite","@id":"https:\/\/swedenbio.se\/en\/#website","url":"https:\/\/swedenbio.se\/en\/","name":"SwedenBIO","description":"Branschorganisationen f\u00f6r svenska life science f\u00f6retag","inLanguage":"en-US","publisher":{"@id":"https:\/\/swedenbio.se\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"SwedenBIO - Branschorganisationen f\u00f6r svenska life science f\u00f6retag","og:type":"article","og:title":"The Future of Venture \u2013 from idea to patient - SwedenBIO","og:description":"From the program on 21 June: 09:00 \u00a6 PROGRAM FROM THE MAIN STAGE Ulf Stenerhag, CEO, Not for sale Ale AB Mats Gustafsson, Founder and CEO, Wednesday Relations AB 10:00 \u00a6 NETWORKING BREAK 10.30 \u00a6 Medicines The authorisation process for medicines Speaker: Marie G\u00e5rdmark, Director of Licensing, Medical Products Agency. Commercialization and life in an","og:url":"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/","article:published_time":"2016-05-24T11:43:37+00:00","article:modified_time":"2023-10-11T07:31:35+00:00","twitter:card":"summary_large_image","twitter:title":"The Future of Venture \u2013 from idea to patient - SwedenBIO","twitter:description":"From the program on 21 June: 09:00 \u00a6 PROGRAM FROM THE MAIN STAGE Ulf Stenerhag, CEO, Not for sale Ale AB Mats Gustafsson, Founder and CEO, Wednesday Relations AB 10:00 \u00a6 NETWORKING BREAK 10.30 \u00a6 Medicines The authorisation process for medicines Speaker: Marie G\u00e5rdmark, Director of Licensing, Medical Products Agency. Commercialization and life in an"},"aioseo_meta_data":{"post_id":"34040","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2023-10-19 02:08:02","updated":"2025-07-01 02:48:31","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/swedenbio.se\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tThe Future of Venture \u2013 from idea to patient\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/swedenbio.se\/en\/"},{"label":"The Future of Venture &#8211; from idea to patient","link":"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/"}],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The Future of Venture - from idea to patient - SwedenBIO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Future of Venture - from idea to patient - SwedenBIO\" \/>\n<meta property=\"og:description\" content=\"From the program on 21 June: 09:00 \u00a6 PROGRAM FROM THE MAIN STAGE Ulf Stenerhag, CEO, Not for sale Ale AB Mats Gustafsson, Founder and CEO, Wednesday Relations AB 10:00 \u00a6 NETWORKING BREAK 10.30 \u00a6 Medicines The authorisation process for medicines Speaker: Marie G\u00e5rdmark, Director of Licensing, Medical Products Agency. Commercialization and life in an [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/\" \/>\n<meta property=\"og:site_name\" content=\"SwedenBIO\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-11T07:31:35+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/kalendarium\\\/the-future-of-venture-from-idea-to-patient\\\/\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/kalendarium\\\/the-future-of-venture-from-idea-to-patient\\\/\",\"name\":\"The Future of Venture - from idea to patient - SwedenBIO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#website\"},\"datePublished\":\"2016-05-24T11:43:37+00:00\",\"dateModified\":\"2023-10-11T07:31:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/kalendarium\\\/the-future-of-venture-from-idea-to-patient\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/swedenbio.se\\\/en\\\/kalendarium\\\/the-future-of-venture-from-idea-to-patient\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/kalendarium\\\/the-future-of-venture-from-idea-to-patient\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Future of Venture &#8211; from idea to patient\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/\",\"name\":\"SwedenBIO\",\"description\":\"Branschorganisationen f\u00f6r svenska life science f\u00f6retag\",\"publisher\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#organization\",\"name\":\"SwedenBIO\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/swedenbio.se\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/swedenbio.se\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/logo.png\",\"width\":240,\"height\":59,\"caption\":\"SwedenBIO\"},\"image\":{\"@id\":\"https:\\\/\\\/swedenbio.se\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Future of Venture - from idea to patient - SwedenBIO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/","og_locale":"en_US","og_type":"article","og_title":"The Future of Venture - from idea to patient - SwedenBIO","og_description":"From the program on 21 June: 09:00 \u00a6 PROGRAM FROM THE MAIN STAGE Ulf Stenerhag, CEO, Not for sale Ale AB Mats Gustafsson, Founder and CEO, Wednesday Relations AB 10:00 \u00a6 NETWORKING BREAK 10.30 \u00a6 Medicines The authorisation process for medicines Speaker: Marie G\u00e5rdmark, Director of Licensing, Medical Products Agency. Commercialization and life in an [&hellip;]","og_url":"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/","og_site_name":"SwedenBIO","article_modified_time":"2023-10-11T07:31:35+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/","url":"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/","name":"The Future of Venture - from idea to patient - SwedenBIO","isPartOf":{"@id":"https:\/\/swedenbio.se\/en\/#website"},"datePublished":"2016-05-24T11:43:37+00:00","dateModified":"2023-10-11T07:31:35+00:00","breadcrumb":{"@id":"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/swedenbio.se\/en\/kalendarium\/the-future-of-venture-from-idea-to-patient\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/swedenbio.se\/en\/"},{"@type":"ListItem","position":2,"name":"The Future of Venture &#8211; from idea to patient"}]},{"@type":"WebSite","@id":"https:\/\/swedenbio.se\/en\/#website","url":"https:\/\/swedenbio.se\/en\/","name":"SwedenBIO","description":"Branschorganisationen f\u00f6r svenska life science f\u00f6retag","publisher":{"@id":"https:\/\/swedenbio.se\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/swedenbio.se\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/swedenbio.se\/en\/#organization","name":"SwedenBIO","url":"https:\/\/swedenbio.se\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/swedenbio.se\/en\/#\/schema\/logo\/image\/","url":"https:\/\/swedenbio.se\/wp-content\/uploads\/2020\/09\/logo.png","contentUrl":"https:\/\/swedenbio.se\/wp-content\/uploads\/2020\/09\/logo.png","width":240,"height":59,"caption":"SwedenBIO"},"image":{"@id":"https:\/\/swedenbio.se\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/sb_events\/34040","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/sb_events"}],"about":[{"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/types\/sb_events"}],"author":[{"embeddable":true,"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/comments?post=34040"}],"version-history":[{"count":1,"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/sb_events\/34040\/revisions"}],"predecessor-version":[{"id":35136,"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/sb_events\/34040\/revisions\/35136"}],"wp:attachment":[{"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/media?parent=34040"}],"wp:term":[{"taxonomy":"sb_event-category","embeddable":true,"href":"https:\/\/swedenbio.se\/en\/wp-json\/wp\/v2\/sb_event-category?post=34040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}